Literature DB >> 24314102

Psychotropic medication use among adolescents: United States, 2005-2010.

Bruce S Jonas1, Qiuping Gu, Juan R Albertorio-Diaz.   

Abstract

Approximately 6.0% of U.S. adolescents aged 12-19 reported psychotropic drug use in the past month. The use of antidepressants (3.2%) and attention deficit hyperactive disorder (ADHD) drugs (3.2%) was highest, followed by antipsychotics (1.0%); anxiolytics, sedatives, and hypnotics (0.5%); and antimanics (0.2%). Males (4.2%) were more likely than females (2.2%) to use ADHD drugs. Females (4.5%) were more likely than males (2.0%) to use antidepressants. Psychotropic drug use was higher among non-Hispanic white (8.2%) adolescents than non-Hispanic black (3.1%) and Mexican-American (2.9%) adolescents. About one-half of U.S. adolescents using psychotropic drugs in the past month had seen a mental health professional in the past year (53.3%). Prior studies have shown an increase in psychotropic medication use among adolescents. However, most studies were based on clinical samples or high-risk populations. This report provides the estimate of any psychotropic medication use in the past month among U.S. noninstitutionalized adolescents aged 12-19 during 2005-2010, using National Health and Nutrition Examination Survey (NHANES) data. Psychotropic medication is a type of drug used to treat clinical psychiatric symptoms or mental disorders. Specific psychotropic drug types addressed are antidepressants; medications for attention deficit hyperactive disorder (ADHD); anxiolytics, sedatives, and hypnotics (ASH); antimanics; and antipsychotics. Adolescents using psychotropic drugs are further examined by sex, race and Hispanic origin, and mental health professional consultation. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24314102

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  10 in total

1.  Interassociation recommendations for developing a plan to recognize and refer student-athletes with psychological concerns at the secondary school level: a consensus statement.

Authors:  Timothy L Neal; Alex B Diamond; Scott Goldman; Karl D Liedtka; Kembra Mathis; Eric D Morse; Margot Putukian; Eric Quandt; Stacey J Ritter; John P Sullivan; Victor Welzant
Journal:  J Athl Train       Date:  2015-03-02       Impact factor: 2.860

Review 2.  Healthcare recommendations for Joubert syndrome.

Authors:  Ruxandra Bachmann-Gagescu; Jennifer C Dempsey; Sara Bulgheroni; Maida L Chen; Stefano D'Arrigo; Ian A Glass; Theo Heller; Elise Héon; Friedhelm Hildebrandt; Nirmal Joshi; Dana Knutzen; Hester Y Kroes; Stephen H Mack; Sara Nuovo; Melissa A Parisi; Joseph Snow; Angela C Summers; Jordan M Symons; Wadih M Zein; Eugen Boltshauser; John A Sayer; Meral Gunay-Aygun; Enza Maria Valente; Dan Doherty
Journal:  Am J Med Genet A       Date:  2019-11-11       Impact factor: 2.802

3.  Trends in Prescription Medication Use Among Children and Adolescents-United States, 1999-2014.

Authors:  Craig M Hales; Brian K Kit; Qiuping Gu; Cynthia L Ogden
Journal:  JAMA       Date:  2018-05-15       Impact factor: 56.272

4.  A prospective study of adolescents' nonmedical use of anxiolytic and sleep medication.

Authors:  Carol J Boyd; Elizabeth Austic; Quyen Epstein-Ngo; Philip T Veliz; Sean Esteban McCabe
Journal:  Psychol Addict Behav       Date:  2014-11-24

5.  Does the Use of Psychotropic Medication Adversely Affect the Outcomes of Hip Arthroscopy?

Authors:  Sylvester T Youlo; Brian E Walczak; James S Keene
Journal:  Am J Sports Med       Date:  2018-10-26       Impact factor: 6.202

6.  Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases.

Authors:  Craig C Reed; Corey J Ketchem; Talya L Miller; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2021-05-28       Impact factor: 11.382

Review 7.  Pharmacogenomics and adverse drug reactions in children.

Authors:  Michael J Rieder; Bruce Carleton
Journal:  Front Genet       Date:  2014-04-16       Impact factor: 4.599

8.  Prescription Psychoactive Medication Use in Adolescent Survivors of Childhood Cancer and Association With Adult Functional Outcomes.

Authors:  Yin Ting Cheung; Wei Liu; Tara M Brinkman; Deokumar Srivastava; Wendy M Leisenring; Rebecca M Howell; Nicole J Ullrich; Karen M Lommel; Pim Brouwers; Todd M Gibson; Leslie L Robison; Gregory T Armstrong; Kevin R Krull
Journal:  JNCI Cancer Spectr       Date:  2020-06-29

9.  Understanding patient-provider discordance in adolescents with lupus: The role of pain and antidepressant medication use.

Authors:  Kathleen Kenney-Riley; Shari Salzhauer Berkowitz; Kimberly Rapoza
Journal:  Health Psychol Open       Date:  2020-12-08

10.  Psychiatric Comorbidities and Psychiatric Medication Use Are Highly Prevalent in Patients With Eosinophilic Esophagitis and Associate With Clinical Presentation.

Authors:  Craig C Reed; S Ryanne Corder; Erin Kim; Emily Sanders; Manaswita Tappata; Swathi Eluri; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2020-06       Impact factor: 12.045

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.